Genflow Biosciences Plc 2023 Year in Review
2023 was a busy and productive year for Genflow Biosciences Plc (“Genflow) marked by significant advancements in our mission to pioneer novel therapeutics for a
Related Articles
GenFlow Bioscience named “a firm to watch” in 2024 by The Guardian
We are thrilled to be named “a firm to watch” by The Guardian. Undoubtedly, the success of our NASH studies this past year and the
Genflow in the Top 50 innovator companies worldwide for 2022
Health Tech World has announced its Top 50 health tech innovators of 2022